Moreover, our previous study demonstrated that Ang II treatment increases the level of MrgD in vivo and vitro, while MrgD ligand Ala alleviates Ang II-induced cardiac hypertrophy [14]. The gene discussed is MRGPRD; the disease is cardiac hypertrophy.